Abstract 19893: Depression Screening in Pediatric Patients With Cardiomyopathy
Introduction: Advances in pediatric heart failure (HF) therapies have resulted in improved survival and a resultant shift toward improving long-term quality of life. Aim of this study was to determine if pediatric cardiomyopathy (CM) patients were at higher risk of depression and, further, to determine if this risk was increased with worsening HF stage.
Methods: We performed a prospective review of all pediatric CM patients screened in our clinic with the 11-Item Kutcher Adolescent Depression Scale (KADS-11). KADS-11 is validated as a screening tool to identify young people at risk for depression. We determined the overall prevalence of abnormal screens in this population and categorized by HF stages.
Results: 911 pediatric patients with CM were screened with the KADS-11. 105 of these patients (12.6%) had abnormal scores, suggestive of high risk of depression. We then categorized patients by AHA/ACC HF Stage. Abnormal screens were present in 9.8% with Stage A HF, 13.5% with Stage B HF, 21.0% with Stage C HF and 33.3% with Stage D HF.
Conclusion: Children with CM are an at-risk population for depression, with greater than one in ten screened patients scoring abnormally. Abnormal KADS-11 scores increase incrementally with progression of HF stage.
Author Disclosures: S. Khan: None. S. Gray: None. C. Mara: None. M. Ashiki: None. J. Brown: None. J.L. Jefferies: None.
- © 2016 by American Heart Association, Inc.